GoKawiil
Tech News
Researchers report that a young boy's cancer went into remission after receiving an experimental form of CAR T cell therapy. The treatment is part of ongoing efforts to adapt CAR T technology, previously effective mainly against blood cancers, to target solid tumors.
American cancer patients are increasingly traveling to China for CAR-T cell therapy, a personalized immunotherapy that reengineers a patient's white blood cells to fight cancer. The Wall Street Journal reports that Chinese providers, having scaled up production, now offer the treatment for $150,000 to $230,000 versus $550,000 to $850,000 in the US, with faster turnaround and included follow-up care.
Scientists are developing genetically modified bacteria designed to seek out and treat tumors from within the body. The approach relies on engineering microbes to recognize cancerous tissue and deliver therapeutic effects directly at the tumor site.